You are here:
25 April 2019 / deal

Loyens & Loeff advised Eurazeo Capital on the acquisition of DORC Group from Montagu

Loyens & Loeff advised Eurazeo Capital, a France-based, leading global investment company listed on Euronext Paris, on the acquisition of DORC (Dutch Ophthalmic Research Center) a Netherlands-based company which operates in the medical technology sector and designs, manufactures and distributes ophthalmic surgery equipment, from Montagu Private Equity, a European private equity firm with headquarters in London.

Eurazeo Capital will invest close to 300M€ in this transaction. DORC will be the fifth investment of Eurazeo Capital IV. This investment perfectly fits the strategy presented during the 2018 Annual Results presentation.

Building windows three colors


Swiss Restructuring & Insolvency in a nutshell

Ever-changing market conditions require businesses to continuously monitor their earnings and liquidity situation as well as their debt structure. read more
Virtual meetings - Law of 23 September 2020

Adoption of corporate resolutions extended until year end

Companies will continue to benefit from simpler formalities for adoption of corporate resolutions until 31 December 2020. read more

A right for employees to be inaccessible

The bill “Right to Inaccessibility Act” has been submitted. Employees are given the right to "be unavailable to perform work outside working hours". read more